Delivery Order SPE2DB20D3104-SPE2DB21FV7Q9
- Not listed
- This federal contract award, valued at $75,845.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other medical commodities. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $10,468.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and medical devices. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award, valued at $127,310.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Cencora, Inc. to supply a comprehensive range of pharmaceutical products and...
- This federal contract award, valued at $115,552.37, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through December 2025. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award, valued at $10,143.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical healthcare commodities. This award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA, valued...
- This federal contract award, valued at $356,080.77, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through November 2026. The award covers the supply of a comprehensive range of pharmaceutical products and medical supplies, including specialty...
- This federal contract award, valued at $39,597.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a...
- This federal contract award, valued at $86,288.13, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract is for the delivery of various pharmaceutical products and medical supplies, including...
- This federal contract award, valued at $14,835.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,452.14 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that was awarded to Cencora, Inc. through the DLA Troop Support Medical program. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB21FV7Q9Delivery Order
This federal contract award, with a ceiling value of $27,510.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for pharmaceutical and medical supplies, including specialty medications, generic drugs, brand-name pharmaceuticals, medical devices, syringes, vials, and other critical medical commodities. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.5k | 5/14/21 |